Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-lactalbumin + probiotic is a nutritional infant formula combination, most notably represented by the product **Modilac Digest 1**. It is designed to improve gastrointestinal tolerance and manage symptoms of infant colic. The formula is enriched with **alpha-lactalbumin**, a major whey protein naturally found in human breast milk that is easily digestible and provides an amino acid profile closer to maternal milk than standard bovine-based formulas. The **probiotic** component typically includes strains such as *Lactobacillus* and *Bifidobacterium* species, which aim to modulate the developing infant gut microbiome, enhance intestinal barrier function, and reduce the incidence of feeding-related gastrointestinal side effects. Clinical studies have demonstrated that this combination supports healthy weight and length gains while significantly improving digestive comfort in infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-lactalbumin + probiotic.